Medication Update for Canadian Pediatric Rheumatology Patients
All of these biologic changes are stressful and confusing! Over the past year, the landscape of biologic treatments available, and coverage for these treatments for children with JIA and other rheumatic diseases has changed. The biggest changes have been a shift to coverage of biosimilar treatments in many provinces, biologic shortages, and phasing out [...]